RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Thomas Forsthuber to Humans

This is a "connection" page, showing publications Thomas Forsthuber has written about Humans.
Connection Strength

0.692
  1. Naoun AA, Raphael I, Forsthuber TG. Immunoregulation via Cell Density and Quorum Sensing-like Mechanisms: An Underexplored Emerging Field with Potential Translational Implications. Cells. 2022 08 06; 11(15).
    View in: PubMed
    Score: 0.042
  2. Chase Huizar C, Ji N, Reddick R, Ostroff GR, Forsthuber TG. Glucan particles as a novel adjuvant for the induction of experimental autoimmune encephalomyelitis. Cell Immunol. 2021 08; 366:104383.
    View in: PubMed
    Score: 0.039
  3. Chase Huizar C, Raphael I, Forsthuber TG. Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis. Cell Immunol. 2020 12; 358:104219.
    View in: PubMed
    Score: 0.037
  4. Raphael I, Joern RR, Forsthuber TG. Memory CD4+ T Cells in Immunity and Autoimmune Diseases. Cells. 2020 02 25; 9(3).
    View in: PubMed
    Score: 0.036
  5. Raphael I, Gomez-Rivera F, Raphael RA, Robinson RR, Nalawade S, Forsthuber TG. TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019 12 19; 4(24).
    View in: PubMed
    Score: 0.035
  6. Robinson RR, Dietz AK, Maroof AM, Asmis R, Forsthuber TG. The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain. Immunotherapy. 2019 02; 11(2):129-147.
    View in: PubMed
    Score: 0.033
  7. Negron A, Robinson RR, St?ve O, Forsthuber TG. The role of B cells in multiple sclerosis: Current and future therapies. Cell Immunol. 2019 05; 339:10-23.
    View in: PubMed
    Score: 0.033
  8. Nalawade SA, Ji N, Raphael I, Pratt A, Kraig E, Forsthuber TG. Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4. Cell Immunol. 2018 09; 331:38-48.
    View in: PubMed
    Score: 0.032
  9. Shoemaker RH, Forsthuber TG. Targeting "Retired Antigens" for Cancer Immunoprevention. Cancer Prev Res (Phila). 2017 11; 10(11):607-608.
    View in: PubMed
    Score: 0.030
  10. Ji N, Forsthuber TG. ELISPOT Techniques. Methods Mol Biol. 2016; 1304:63-71.
    View in: PubMed
    Score: 0.027
  11. Forsthuber TG, Radstake TR. Expert Review of Clinical Immunology 10-year anniversary issue. Foreword. Expert Rev Clin Immunol. 2015 Jan; 11(1):1-3.
    View in: PubMed
    Score: 0.025
  12. Raphael I, Webb J, Stuve O, Haskins W, Forsthuber T. Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future. Expert Rev Clin Immunol. 2015 Jan; 11(1):69-91.
    View in: PubMed
    Score: 0.025
  13. Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015 Jul; 74(1):5-17.
    View in: PubMed
    Score: 0.025
  14. Ji N, Somanaboeina A, Dixit A, Kawamura K, Hayward NJ, Self C, Olson GL, Forsthuber TG. Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis. J Immunol. 2013 Nov 15; 191(10):5074-84.
    View in: PubMed
    Score: 0.023
  15. Raphael I, Forsthuber TG. Stability of T-cell lineages in autoimmune diseases. Expert Rev Clin Immunol. 2012 May; 8(4):299-301.
    View in: PubMed
    Score: 0.021
  16. Sosa RA, Forsthuber TG. The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis. J Interferon Cytokine Res. 2011 Oct; 31(10):753-68.
    View in: PubMed
    Score: 0.020
  17. Ji N, Sosa RA, Forsthuber TG. More than just a T-box: the role of T-bet as a possible biomarker and therapeutic target in autoimmune diseases. Immunotherapy. 2011 Mar; 3(3):435-41.
    View in: PubMed
    Score: 0.019
  18. Forsthuber TG, Muraro P. Is there a place for 'immuno' in the immunotherapy of multiple sclerosis? Immunotherapy. 2009 May; 1(3):329-31.
    View in: PubMed
    Score: 0.017
  19. Kawamura K, McLaughlin KA, Weissert R, Forsthuber TG. Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice. J Immunol. 2008 Sep 01; 181(5):3202-11.
    View in: PubMed
    Score: 0.016
  20. Kort JJ, Kawamura K, Fugger L, Weissert R, Forsthuber TG. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. J Neuroimmunol. 2006 Apr; 173(1-2):23-34.
    View in: PubMed
    Score: 0.013
  21. Denkinger CM, Metz C, Fingerle-Rowson G, Denkinger MD, Forsthuber T. Macrophage migration inhibitory factor and its role in autoimmune diseases. Arch Immunol Ther Exp (Warsz). 2004 Nov-Dec; 52(6):389-400.
    View in: PubMed
    Score: 0.012
  22. Klehmet J, Shive C, Guardia-Wolff R, Petersen I, Spack EG, Boehm BO, Weissert R, Forsthuber TG. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis. Clin Immunol. 2004 Apr; 111(1):53-60.
    View in: PubMed
    Score: 0.012
  23. Jeffreys S, Chambers JP, Yu JJ, Hung CY, Forsthuber T, Arulanandam BP. Insights into Acinetobacter baumannii protective immunity. Front Immunol. 2022; 13:1070424.
    View in: PubMed
    Score: 0.011
  24. Forsthuber TG, Shive CL, Wienhold W, de Graaf K, Spack EG, Sublett R, Melms A, Kort J, Racke MK, Weissert R. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J Immunol. 2001 Dec 15; 167(12):7119-25.
    View in: PubMed
    Score: 0.010
  25. Manouchehri N, Hussain RZ, Cravens PD, Esaulova E, Artyomov MN, Edelson BT, Wu GF, Cross AH, Doelger R, Loof N, Eagar TN, Forsthuber TG, Calvier L, Herz J, St?ve O. CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity. Proc Natl Acad Sci U S A. 2021 04 06; 118(14).
    View in: PubMed
    Score: 0.010
  26. Hung CY, Zhang H, Castro-Lopez N, Ostroff GR, Khoshlenar P, Abraham A, Cole GT, Negron A, Forsthuber T, Peng T, Galgiani JN, Ampel NM, Yu JJ. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection. Infect Immun. 2018 11; 86(11).
    View in: PubMed
    Score: 0.008
  27. Narayan RN, Forsthuber T, St?ve O. Emerging drugs for primary progressive multiple sclerosis. Expert Opin Emerg Drugs. 2018 06; 23(2):97-110.
    View in: PubMed
    Score: 0.008
  28. Bloom J, Metz C, Nalawade S, Casabar J, Cheng KF, He M, Sherry B, Coleman T, Forsthuber T, Al-Abed Y. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential. J Biol Chem. 2016 Dec 16; 291(51):26502-26514.
    View in: PubMed
    Score: 0.007
  29. Ketter P, Yu JJ, Cap AP, Forsthuber T, Arulanandam B. Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis. Expert Rev Clin Immunol. 2016; 12(5):501-7.
    View in: PubMed
    Score: 0.007
  30. Latham LB, Lee MJ, Lincoln JA, Ji N, Forsthuber TG, Lindsey JW. Antivirus immune activity in multiple sclerosis correlates with MRI activity. Acta Neurol Scand. 2016 Jan; 133(1):17-24.
    View in: PubMed
    Score: 0.006
  31. St?ve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von B?dingen HC, Centonze D, Forsthuber TG, Knappertz V. CD19 as a molecular target in CNS autoimmunity. Acta Neuropathol. 2014 Aug; 128(2):177-90.
    View in: PubMed
    Score: 0.006
  32. Li W, Murthy AK, Lanka GK, Chetty SL, Yu JJ, Chambers JP, Zhong G, Forsthuber TG, Guentzel MN, Arulanandam BP. A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice. Vaccine. 2013 Nov 19; 31(48):5722-8.
    View in: PubMed
    Score: 0.006
  33. Trivedi NH, Guentzel MN, Rodriguez AR, Yu JJ, Forsthuber TG, Arulanandam BP. Mast cells: multitalented facilitators of protection against bacterial pathogens. Expert Rev Clin Immunol. 2013 Feb; 9(2):129-38.
    View in: PubMed
    Score: 0.005
  34. Murthy AK, Li W, Chaganty BK, Kamalakaran S, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP. Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun. 2011 Jul; 79(7):2928-35.
    View in: PubMed
    Score: 0.005
  35. Cantor JR, Yoo TH, Dixit A, Iverson BL, Forsthuber TG, Georgiou G. Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proc Natl Acad Sci U S A. 2011 Jan 25; 108(4):1272-7.
    View in: PubMed
    Score: 0.005
  36. Yu JJ, Goluguri T, Guentzel MN, Chambers JP, Murthy AK, Klose KE, Forsthuber TG, Arulanandam BP. Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice. Clin Vaccine Immunol. 2010 Feb; 17(2):215-22.
    View in: PubMed
    Score: 0.004
  37. Jane-wit D, Altuntas CZ, Monti J, Johnson JM, Forsthuber TG, Tuohy VK. Sex-defined T-cell responses to cardiac self determine differential outcomes of murine dilated cardiomyopathy. Am J Pathol. 2008 Jan; 172(1):11-21.
    View in: PubMed
    Score: 0.004
  38. Murthy AK, Cong Y, Murphey C, Guentzel MN, Forsthuber TG, Zhong G, Arulanandam BP. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect Immun. 2006 Dec; 74(12):6722-9.
    View in: PubMed
    Score: 0.004
  39. Macaubas C, Wahlstrom J, Galv?o da Silva AP, Forsthuber TG, S?nderstrup G, Kwok WW, DeKruyff RH, Umetsu DT. Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals. J Immunol. 2006 Apr 15; 176(8):5069-77.
    View in: PubMed
    Score: 0.003
  40. Hofstetter HH, Targoni OS, Karulin AY, Forsthuber TG, Tary-Lehmann M, Lehmann PV. Does the frequency and avidity spectrum of the neuroantigen-specific T cells in the blood mirror the autoimmune process in the central nervous system of mice undergoing experimental allergic encephalomyelitis? J Immunol. 2005 Apr 15; 174(8):4598-605.
    View in: PubMed
    Score: 0.003
  41. Weissert R, Kuhle J, de Graaf KL, Wienhold W, Herrmann MM, M?ller C, Forsthuber TG, Wiesm?ller KH, Melms A. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes. J Immunol. 2002 Jul 01; 169(1):548-56.
    View in: PubMed
    Score: 0.003
  42. Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 1998 Jul 31; 281(5377):703-6.
    View in: PubMed
    Score: 0.002
  43. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today. 1993 May; 14(5):203-8.
    View in: PubMed
    Score: 0.001
  44. Oster W, Forsthuber T, Hennekeuser HH, Gamm H, Lindemann A, Schmitz G, Fuhr HG, Hinterberger R, Kreiter H, Thoenes W, et al. MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphoma. Blut. 1990 Jan; 60(1):23-7.
    View in: PubMed
    Score: 0.001
  45. Schmidt H, Forsthuber T, B?hring HJ, M?ller CA. Differential expression of the HLA-B7 and the HLA-A2 gene in transfected mouse L(tk-) cells after stimulation by mouse interferon. Immunobiology. 1987 Jan; 174(1):51-66.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support